Skip to main content
SpringerLink
Log in
Book cover

Clinical Nephrotoxins pp 483–494Cite as

Radiocontrast agents

  • Chapter

  • 258 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275: 1489–1494.

    CAS  PubMed  Google Scholar 

  2. Porter GA. Contrast-associated nephropathy: presentation, pathophysiology and management. Mineral & Electrolyte Metabolism 1994; 20: 232–243.

    CAS  Google Scholar 

  3. Kurnik BR, Allgren RI, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kid Dis. 1998; 31:674–80

    CAS  PubMed  Google Scholar 

  4. Gruberg L., Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 h of interventional coronaryprocedures in patients with pre-existing chronic renal insufficiency. J Am Coll Cardiol. 2000; 36:1542–8.

    Article  CAS  PubMed  Google Scholar 

  5. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB: Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary antioplasty in patients with preexisiting renal insufficiency. Am J. Cardiol. 1999; 83;260–3.

    Article  CAS  PubMed  Google Scholar 

  6. Berns AS. Nephrotoxicity of contrast media (clinical conference). Kidney Int 1989; 36: 730–740.

    CAS  PubMed  Google Scholar 

  7. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O’Dea F, Stone E, Reddy R, McManamon PJ. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274–1279.

    CAS  PubMed  Google Scholar 

  8. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypert 1996; 5: 127–133.

    CAS  Google Scholar 

  9. Moreau JF, Droz D, Sabto J, Jungers P, Kleinknecht D, Hinglais N, Michel JR. Osmotic nephrosis induced by water soluble triiodinated contrast media in man. Radiology 1975; 115: 329–336.

    CAS  PubMed  Google Scholar 

  10. Bettmann MA. The evaluation of contrast-related renal failure (comment). AJR Am J Roentgenol 1991; 157: 66–68.

    CAS  PubMed  Google Scholar 

  11. Hunter JV, Kind PRN. Nonionic iodinated contrast media: potential renal damage assessed with enzymuria. Radiology 1992; 183: 101–104.

    CAS  PubMed  Google Scholar 

  12. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Müller C, Osswald H. Prevention of radiocontrast-media-induced nephropathy in patients with preexisting renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 1999; 14: 1146–1149.

    CAS  PubMed  Google Scholar 

  13. Donadio C, Tramonti G, Giordani R, Lucchetti A, Calderazzi A, Sbragia P, Bianchi C. Glomerular and tubular effects of ionic and nonionic contrast media (diatrizoate and iopamidol). Contrib Nephrol 1988; 68: 212–219.

    CAS  PubMed  Google Scholar 

  14. Porter GA. Urinary biomarkers and nephrotoxicity. Mineral&Electrolyte Metabolism 1994; 20: 181–186.

    CAS  Google Scholar 

  15. Scanlon PJ, Faxon DP, Audet AM, Carabello, B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JD, Nissen SE, Pepine CJ, Watson, RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A, Russell RO, Ryan TJ, Smith SC: ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Associateion Task force on Practic Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol. 1999; 33:1756–824.

    Article  CAS  PubMed  Google Scholar 

  16. Tervahartiala P, Kivisaari L, Kivisaari R, Vehmas T, Virtanen I. Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 1997; 76: 96–102.

    CAS  PubMed  Google Scholar 

  17. Dobrota M, Powell CJ, Holtz E, Wallin A, Vik H. Biochemical and morphological effects of contrast media on the kidney. Acta Radiol (Suppl) 1995; 399: 196–203.

    CAS  Google Scholar 

  18. Battenfeld R, Khater AE, Drommer W, Guenzel P, Kaup FJ. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats (see comments). Invest Radiol 1991; 26: 35–39.

    CAS  PubMed  Google Scholar 

  19. Heyman SN, Brezis M, Reubinoff CA, Greenfeld Z, Lechene C, Epstein FH, Rosen S. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988; 82: 401–412.

    CAS  PubMed  Google Scholar 

  20. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237–1242.

    CAS  Google Scholar 

  21. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989; 110: 119–124.

    CAS  PubMed  Google Scholar 

  22. D’Elia JA, Gleason RE, Alday M, Malarick C, Godley K, Warram J, Kaldany A, Weinrauch LA. Nephrotoxicity from angiographic contrast material. A prospective study. Am J Med 1982; 72: 719–725.

    CAS  Google Scholar 

  23. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615–620.

    Article  CAS  PubMed  Google Scholar 

  24. Agrawal M, Stouffer GA: Contrast induced nephropathy after angiography. Am J Med Sci. 2002;323:252–58.

    PubMed  Google Scholar 

  25. Rosovsky MA, Rusinek H, Berenstein A, Basak S, Setton A, Nelson PK. High-dose administration of nonionic contrast media: a retrospective review. Radiology 1996; 200: 119–122.

    CAS  PubMed  Google Scholar 

  26. Rudnicki M, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 1996; 5: 127–133.

    Google Scholar 

  27. Vanzee BE, Hoy WE, Talley TE, Jaenike JR. Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 1978; 89: 51–54.

    CAS  PubMed  Google Scholar 

  28. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992; 182: 649–655.

    CAS  PubMed  Google Scholar 

  29. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winneford M, Cohen MB, Vanfossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254–261.

    CAS  PubMed  Google Scholar 

  30. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143–149.

    CAS  PubMed  Google Scholar 

  31. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S. Radiocontrast-associated renal dysfunction: incidence and risk factors (see comments). AJR Am J Roentgenol 1991; 157: 49–58.

    CAS  PubMed  Google Scholar 

  32. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephroathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259–265.

    CAS  PubMed  Google Scholar 

  33. Gomes AS, Baker JD, Martin-Paredero V, Dixon SM, Takiff H, Machleder HI, Moore WS. Acute renal dysfunction after major arteriography. AJR Am J Roentgenol 1985; 145(6): 1249–1253.

    CAS  PubMed  Google Scholar 

  34. Taliercio CP, McCallister SH, Holmes DR, Ilstrup DM, Vlietstra RE. Nephrotoxicity of nonionic contrast media after cardiac angiography. Am J Cardiol 1989; 64: 815–816.

    Article  CAS  PubMed  Google Scholar 

  35. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Sem Nephrol 1997; 17: 15–26.

    CAS  Google Scholar 

  36. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649–652.

    CAS  PubMed  Google Scholar 

  37. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology 1992; 183: 519–521.

    CAS  PubMed  Google Scholar 

  38. Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994; 2: 153–157.

    CAS  PubMed  Google Scholar 

  39. Katzberg RW, Morris TW, Burgener FA, Kamm DE, Fischer HW. Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 1977; 12: 381–388

    CAS  PubMed  Google Scholar 

  40. Bakris GL, Burnett JCJ. A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 1985; 27: 465–468.

    CAS  PubMed  Google Scholar 

  41. Caldicott WJ, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970; 5: 539–547.

    CAS  PubMed  Google Scholar 

  42. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297–312.

    CAS  PubMed  Google Scholar 

  43. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C. Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983; 18: 160–166.

    CAS  PubMed  Google Scholar 

  44. Larson TS, Hudson K, Mertz JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med 1983; 101: 385–391.

    CAS  PubMed  Google Scholar 

  45. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58–65.

    CAS  PubMed  Google Scholar 

  46. Oldroyd SD, Haylor JL, Morcos SK. Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media. Radiology 1995; 196: 661–665.

    CAS  PubMed  Google Scholar 

  47. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451–1458.

    CAS  PubMed  Google Scholar 

  48. Erley CM, Osswald H. Prevention of contrast media-induced renal impairment by adenosine antagonists in humans. Drug Dev Res 1998; 45: 172–175.

    Article  CAS  Google Scholar 

  49. Arend LJ, Bakris GL, Burnett JCJ, Megerian C, Spielman WS. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987; 110: 406–411.

    CAS  PubMed  Google Scholar 

  50. Katholi RE, Taylor GJ, McCann WP, Woods WT, Womack KA, McCoy CD, Katholi CR, Moses HW, Mishkel GJ, Lucore CL, Holloway RM, Miller BD, Woodruff RC, Dove JT, Mikell FL, Schneider JA. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995; 195: 17–22.

    CAS  PubMed  Google Scholar 

  51. Osswald H, Schmitz HJ, Heidenreich O. Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia. Pflugers Arch 1975; 357: 323–333.

    Article  CAS  PubMed  Google Scholar 

  52. Hall JE, Granger JP. Adenosine alters glomerular filtration control by angiotensin II. Am J Physiol 1986; 250: F917–F923.

    CAS  PubMed  Google Scholar 

  53. Haas JA, Osswald H. Adenosine induced fall in glomerular capillary pressure: effect of ureteral obstruction and aortic constriction in the Munich-Wistar rat kidney. Naunyn Schmiedebergs Arch Pharmacol 1981; 317: 86–89.

    Article  CAS  PubMed  Google Scholar 

  54. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993; 44: 1217–1223.

    CAS  PubMed  Google Scholar 

  55. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632–642.

    CAS  PubMed  Google Scholar 

  56. Cederholm C, Almen T, Bergqvist D, Golman K, Takolander R. Acute renal failure in rats. Interaction between contrast media and temporary renal arterial occlusion. Acta Radiol 1989; 30: 321–326.

    CAS  PubMed  Google Scholar 

  57. Deray G, Dubois M, Martinez F, Baumelou B, Beaufils H, Bourbouze R, Baumelou A, Jacobs C. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990; 10: 507–513.

    CAS  PubMed  Google Scholar 

  58. Osswald H, Schmidt HJ, Kemper R. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflügers Arch 1977; 371: 45–49.

    Article  CAS  PubMed  Google Scholar 

  59. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radio-contrast toxicity in the rat. J Clin Invest 1994; 94: 1069–1075.

    CAS  PubMed  Google Scholar 

  60. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG: Role of adenosine in constrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000; 75: 1275–83.

    CAS  PubMed  Google Scholar 

  61. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A: Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hyperten. 1997; 29(1Pt2): 274–9.

    CAS  Google Scholar 

  62. Osswald H, Helminger I, Jendralski A, Abrar B. Improvement of renal function by theophylline in the acute renal failure of the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 1979; 307: R47 (abstract).

    Google Scholar 

  63. Gouyon JB, Guignard JP. Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 1988; 33: 1078–1083.

    CAS  PubMed  Google Scholar 

  64. Deray G, Martinez F, Cacoub P, Baumelou B, Baumelou A, Jacobs C. A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990; 10: 316–322.

    CAS  PubMed  Google Scholar 

  65. Rossi N, Ellis V, Kontry T, Gunther S, Churchill P, Bidani A. The role of adenosine in HgCl2-induced acute renal failure in rats. Am J Physiol 1990; 258: F1554–F1560.

    CAS  PubMed  Google Scholar 

  66. Lin JJ, Churchill PC, Bidani AK. Theophylline in rats during maintenance phase of post-ischemic acute renal failure. Kidney Int 1988; 33: 24–28.

    CAS  PubMed  Google Scholar 

  67. Lin JJ, Churchill PC, Bidani AK. Effect of theophylline on the initiation phase of postischemic acute renal failure in rats. J Lab Clin Med 1986; 108: 150–154.

    CAS  PubMed  Google Scholar 

  68. Bidani AK, Churchill PC. Aminophylline ameliorates glycerol-induced acute renal failure in rats. Can J Physiol Pharmacol 1983; 61: 567–571.

    CAS  PubMed  Google Scholar 

  69. Bidani AK, Churchill PC, Packer W. Theophylline-induced protection in myoglobinuric acute renal failure: Further chracterization. Can J Physiol Pharmacol 1987; 65: 42–45.

    CAS  PubMed  Google Scholar 

  70. Erley CM, Heyne N, Burgert K, Langanke J, Risler T, Osswald H. Prevention of radiocontrast induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol 1997; 8: 1125–1132.

    CAS  PubMed  Google Scholar 

  71. Barrett BJ, Parfrey PS, McDonald JR, Hefferton DM, Reddy ER, McManamon PJ. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial (see comments). Radiology 1992; 183: 105–110.

    CAS  PubMed  Google Scholar 

  72. Deray G, Jacobs C. Radiocontrast nephrotoxicity. A review. Invest Radiol 1995; 30: 221–225.

    CAS  PubMed  Google Scholar 

  73. Katholi RE, Taylor GJ, Woods WT, Womack KA, Katholi CR, McCann WP, Moses HW, Dove JT, Mikell FL, Woodruff RC. Nephro-toxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings. Radiology 1993; 186: 183–187.

    CAS  PubMed  Google Scholar 

  74. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989; 320: 149–153.

    CAS  PubMed  Google Scholar 

  75. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993; 188: 171–178.

    CAS  PubMed  Google Scholar 

  76. Jakobsen JA. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol (Suppl) 1995; 399: 191–195.

    CAS  Google Scholar 

  77. Jakobsen JA. Renal experience with Visipaque. Eur Radiol 1996; 6(Suppl 2): S16–S19.

    PubMed  Google Scholar 

  78. Weissleder R. Can gadolinium be safely given in renal failure? AJR Am J Roentgenol 1996; 167: 278–279.

    CAS  PubMed  Google Scholar 

  79. Kaufman JA, Geller SC, Waltman AC. Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 1996; 198: 579–581.

    CAS  PubMed  Google Scholar 

  80. Hatrick AG, Jarosz JM, Irvine AT. Gadopentate dimeglumine as an alternative contrast agent for use in interventional procedures. Clin Radiology 1997; 52: 948–952.

    CAS  Google Scholar 

  81. Seeger JM, Self S, Harward TR, Flynn TC, Hawkins IF Jr. Carbon dioxide gas as an arterial contrast agent. Ann Surgery 1993; 217: 688–697.

    CAS  Google Scholar 

  82. Hawkins IF Jr, Wilcox CS, Kerns SR, Sabatelli FW. CO2 digital angiography: a safer contrast agent for renal vascular imaging? Am J Kidney Dis 1994; 24: 685–694.

    PubMed  Google Scholar 

  83. Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416–1420.

    CAS  PubMed  Google Scholar 

  84. Kurnik BR, Weisberg LS, Cuttler IM, Kurnik PB. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J Lab Clin Med 1990; 116: 27–36.

    CAS  PubMed  Google Scholar 

  85. Weisberg LS, Kurnik PB, Kurnik BR. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Renal Failure 1993; 15: 61–68.

    CAS  PubMed  Google Scholar 

  86. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992; 41: 1408–1415.

    CAS  PubMed  Google Scholar 

  87. Anto HR, Chou SY, Porush JG, Shapiro WB. Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 1981; 141: 1652–1656.

    Article  CAS  PubMed  Google Scholar 

  88. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Radiol 1981; 136: 859–861.

    CAS  Google Scholar 

  89. Carraro M, Stacul F, Collari P, Toson D, Zucconi F, Torre R, Faccini L, Dalla Palma L. Contrast media nephrotoxicity: urinary protein and enzyme pattern in patients with or without saline infusion during digital subtracting angiography. Contrib Nephrol 1993; 101: 251–254.

    CAS  PubMed  Google Scholar 

  90. Kerstein MD, Puyau FA. Value of periangiography hydration. Surgery 1984; 96: 919–922.

    CAS  PubMed  Google Scholar 

  91. Louis BM, Hoch BS, Hernandez C, Namboodiri N, Neiderman G, Nissenbaum A, Foti FP, Magno A, Banayat G, Fata F, Manohar NL, Lipner HI. Protection from the nephrotoxicity of contrast dye. Renal Failure 1996; 18: 639–646.

    CAS  PubMed  Google Scholar 

  92. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992; 62: 413–415.

    CAS  PubMed  Google Scholar 

  93. Golman K, Cederholm C. Contrast medium-induced acute renal failure. Can it be prevented? Invest. Radiol. 1990; 25(Suppl 1): S127–S128.

    PubMed  Google Scholar 

  94. Neumayer HH, Gellert J, Luft FC. Calcium antagonists and renal protection. Renal Failure 1993; 15: 353–358.

    CAS  PubMed  Google Scholar 

  95. Russo D, Testa A, Volpe LD, Sansone G. Randomised propspective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 1990; 55: 254–257.

    CAS  PubMed  Google Scholar 

  96. Carraro M, Mancini W, Artero M, Stacul F, Grotto M, Cova M, Faccini L. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transplant 1996; 11: 444–448.

    CAS  PubMed  Google Scholar 

  97. Spangberg Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function? Scand J Urol Nephrol 1996; 30: 63–68.

    CAS  PubMed  Google Scholar 

  98. Khoury Z, Schlicht JR, Como J, Karschner JK, Shapiro AP, Mook WJ, Weber RJ. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacother 1995; 15: 59–65.

    CAS  Google Scholar 

  99. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, Bull DA, McIntyre KE, Bernhard VM, Misiorowski RL. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992; 53: 317–320.

    Article  CAS  PubMed  Google Scholar 

  100. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 1996; 101: 49–53.

    Article  CAS  PubMed  Google Scholar 

  101. Madyoon H, Croushore L, Weaver D, Mathur V: Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Cather Cardiovasc. Intervent 2001; 53: 341–5.

    CAS  Google Scholar 

  102. Kini A, Sharma S: Managing the high-risk patients: Experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention. Rev Cardiovas Med. 2001; 2(s1): S19–25.

    Google Scholar 

  103. Wambach G, Winkert T. Nierenfunktionsstörungen nach Röntgenkontrastmittelgabe: Prophylaxe durch das atriale natriuretische Peptid? Nieren-und Hochdruckkrankheiten 1990; 19: 312–317.

    Google Scholar 

  104. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674–680.

    CAS  PubMed  Google Scholar 

  105. Erley CM, Duda SH, Schlepckow S, Koehler J, Huppert PE, Strohmaier WL, Bohle A, Risler T, Osswald H. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994; 45: 1425–1431.

    CAS  PubMed  Google Scholar 

  106. Erley CM. Prävention des kontrastmittelbedingten Nierenversagens. Intensivmed 1997; 34: 769–777.

    Article  Google Scholar 

  107. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. New Engl J MED 2000; 343: 180–184.

    Article  CAS  PubMed  Google Scholar 

  108. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial). Am J Cardiol. 2002; 89: 356–8.

    Article  CAS  PubMed  Google Scholar 

  109. Adamian MG, Mousssa I, Mehran R: the role of mucomyst administration prior to percutaneous intervention on renal function in patients with chronic renal failure. J Am Coll Cardiol. 2002; 39(sA): 1A.

    Google Scholar 

  110. Mouhayar EN, Tadros G, Akinwande AAO: Prevention of contrast-induced renal dysfunction with acetylcysteine in patients undergoing conronary angiography. J Am Coll Cardiol. 2002: 39(sA): 1A.

    Google Scholar 

  111. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002; 40: 298–303.

    CAS  PubMed  Google Scholar 

  112. Oldroyd S, Slee SJ, Haylor J, Morcos SK, Wilson C. Role for endothelin in the renal responses to radiocontrast media in the rat. Clin Sci Colch 1994; 87: 427–434.

    CAS  PubMed  Google Scholar 

  113. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675–1680.

    CAS  PubMed  Google Scholar 

  114. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstandt H, Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 1998; 13: 358–362.

    CAS  PubMed  Google Scholar 

  115. Berger ED, Bader BD, Bosker J, Risler T, Erley CM. Kontrastmittelinduziertes Nierenversagen läßt sich durch Hämodialyse nicht verhindern. (Contrast media-induced kidney failure cannot be prevented by hemodialysis). Dtsch Med Wochenschr 2001; 16; 126(7): 162–166 (German).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Tübingen, Germany

    Christiane M. Erley

  2. Oregon Health Sciences University, Portland, Oregon, USA

    George A. Porter

Authors
  1. Christiane M. Erley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George A. Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nephrology and Hypertension, University of Antwerp, Belgium

    Marc E. de Broe

  2. Department of Medicine, The Oregon Health Sciences University, Portland, Oregon, USA

    George A. Porter

  3. Northwest Renal Clinic, Legacy Good Samaritan Hospital, Portland, Oregon, USA

    William M. Bennett

  4. Department of Nephrology and Hypertension, University of Antwerp, Belgium

    Gert A. Verpooten

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Erley, C.M., Porter, G.A. (2003). Radiocontrast agents. In: de Broe, M.E., Porter, G.A., Bennett, W.M., Verpooten, G.A. (eds) Clinical Nephrotoxins. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2586-6_23

Download citation

  • DOI: https://doi.org/10.1007/1-4020-2586-6_23

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-1277-8

  • Online ISBN: 978-1-4020-2586-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation